Sarah Payton. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Androgen Antagonists/therapeutic useAntineoplastic Agents, Hormonal/therapeutic useHumansMaleNeoplasms, Hormone-Dependent/drug therapyNeoplasms, Hormone-Dependent/mortalityProstatic Neoplasms/drug therapyProstatic Neoplasms/mortality
Substances: See more » Androgen AntagonistsAntineoplastic Agents, Hormonal
Year: 2014 PMID: 25069734 DOI: 10.1038/nrurol.2014.187
Source DB: PubMed Journal: Nat Rev Urol ISSN: 1759-4812 Impact factor: 14.432